<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230102057023N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-21</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Emotion Regulation Therapy for Cancer Caregivers and Cognitive Behavioral Therapy</public_title>
      <acronym>ERT-C, CBT</acronym>
      <scientific_title>Comparison of the Effectiveness of Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy (CBT) on Depression and anxiety symptoms, Emotion Regulation Deficits, Perseverative Negative Thinking</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67964</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: The randomization of this study was done by limited randomization method and block randomization type with random block sizes with individual randomization unit and through random allocation software. Opaque sealed envelopes with a random sequence were used to conceal the random allocation, Blinding description: In this study, the person providing the treatment is unaware of the outcome variables. The person who evaluates the outcome variables is unaware of the objectives and hypotheses of the study, and the data analyst is unaware of the intervention groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Anxiety. Condition 2: Depression. Condition 3: Cancer. Condition 4: Caregiving.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention group: This group receives emotion regulation therapy  for cancer caregivers in 8 sessions in a group setting. This treatment includes psychoeducation for a better understanding of emotions and their underlying motivations, training in cue detection and self-monitoring skills , training in identifying reactive responses to emotions, training in self-regulation skills including "orienting and allowing", training in metacognitive skills in emotion regulation. "Courageous and Compassionate reframing", Courage and Compassion meditation training, imaginative confrontation technique for facing perceived fears and frustrations and practicing conflicting voices. Intervention 2: Second Intervention group: This group receives cognitive behavioral therapy in 8 sessions in a group setting. This treatment includes psychoeducation, goal direction and explaining the principles of cognitive behavioral therapy, effective coping training, identifying maladaptive cognitions and ineffective beliefs, challenging and reconstructing maladaptive cognitions, behavioral activation, problem solving, training communication and assertiveness skills.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All participant data can be shared after de-identification.

When:
Start of the access period: 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions

Conditions:
Providing the data is only for a better understanding of the method of this research. Therefore, analysis on the data is not allowed.

Where to obtain:
Kimia Kasaei nasab: kimia.kn@resident.mui.ac.ir , shirin_kasa@yahoo.com Phone: +989113548069
Dr. Reza Bagherian : bagherian@med.mui.ac.ir , Isfahan, Hezar Jarib Street, Isfahan University of Medical Sciences, Medical School, Department of Health Psychology, Postal Code: 8174673461

How to obtain:
First, send an email to Mrs. Kesai Nesab, if you do not receive a response from the university email, send a message to the personal email. And otherwise, send a message to Dr. Reza Bagharian's email. We try to respond within a week

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kimia Kasaei nasab</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 9313</telephone>
        <email>kimia.kn@resident.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Bagherian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jarib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 9313</telephone>
        <email>bagherian@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being at least 18 years of age
A self-report of caregiving of a cancer patient with any stage of any type of cancer</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of hospitalization due to mental disorder
Participation in other psychosocial trials
Scoring lower than cutoff criteria on the Distress Thermometer measure (DT&lt;4)
Scoring lower than cutoff criteria on the Brief Penn State Worry Questionnaire (&lt;15)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z63.7</hc_code>
      <hc_code>F32</hc_code>
      <hc_code>Z85.9</hc_code>
      <hc_code>Y93.F</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other stressful life events affecting family and household</hc_keyword>
      <hc_keyword>Major depressive disorder, single episode</hc_keyword>
      <hc_keyword>Personal history of malignant neoplasm, unspecified</hc_keyword>
      <hc_keyword>Activities involving caregiving</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention group: This group receives emotion regulation therapy  for cancer caregivers in 8 sessions in a group setting. This treatment includes psychoeducation for a better understanding of emotions and their underlying motivations, training in cue detection and self-monitoring skills , training in identifying reactive responses to emotions, training in self-regulation skills including "orienting and allowing", training in metacognitive skills in emotion regulation. "Courageous and Compassionate reframing", Courage and Compassion meditation training, imaginative confrontation technique for facing perceived fears and frustrations and practicing conflicting voices.</i_keyword>
      <i_keyword>Second Intervention group: This group receives cognitive behavioral therapy in 8 sessions in a group setting. This treatment includes psychoeducation, goal direction and explaining the principles of cognitive behavioral therapy, effective coping training, identifying maladaptive cognitions and ineffective beliefs, challenging and reconstructing maladaptive cognitions, behavioral activation, problem solving, training communication and assertiveness skills.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression and anxiety Symptoms Score in Hospital Anxiety and Depression Scale. Timepoint: Before intervention, After intervention, 3 months after intervention. Method of measurement: Distress thermometer, and Hospital Anxiety and Depression Scale.</prim_outcome>
      <prim_outcome>Emotion Regulation Deficits score in Difficulties in Emotion Regulation Scale. Timepoint: Before intervention, After intervention, and 3 months after intervention. Method of measurement: Difficulties in Emotion Regulation Scale.</prim_outcome>
      <prim_outcome>Perseverative Negative Thinking score in Penn State Worry Questionnaire and Ruminative Response Scale. Timepoint: Before intervention, After intervention, and 3 months after intervention. Method of measurement: Penn State Worry Questionnaire and Ruminative Response Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-15</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezar Jarib Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
